Abbott Laboratories (ABT) Drug Pipeline
| Drug Name | Condition | Stage | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Itopride Hydrochloride 150 Mg Extended Release Tablets, Itopride Hydrochloride 50 Mg Film Coated Tablets | Functional Dyspepsia | Phase III | Active Not Recruiting | Trial of Itopride 150mg Once a Day Versus Itopride 50 mg Thrice a Day; in Patients With Functional Dyspepsia | Nov 24, 2023 | ― |
| Mebeverine+Simethicone, Mebeverine, Simethicone | Functional Bowel Disorder | Phase III | Completed | Efficacy and Safety of Mebeverine + Simethicone in Patients With Functional Bowel Disorders | Dec 14, 2021 | ― |
| Drug Name | Stage | Condition | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Itopride Hydrochloride 150 Mg Extended Release Tablets, Itopride Hydrochloride 50 Mg Film Coated Tablets | Phase III | Functional Dyspepsia | Active Not Recruiting | Trial of Itopride 150mg Once a Day Versus Itopride 50 mg Thrice a Day; in Patients With Functional Dyspepsia | Nov 24, 2023 | ― |
| Mebeverine+Simethicone, Mebeverine, Simethicone | Phase III | Functional Bowel Disorder | Completed | Efficacy and Safety of Mebeverine + Simethicone in Patients With Functional Bowel Disorders | Dec 14, 2021 | ― |
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Abbott Laboratories (MX:ABT) have in its pipeline
Abbott Laboratories MX:ABT is currently developing the following drugs: Itopride Hydrochloride 150 Mg Extended Release Tablets, Itopride Hydrochloride 50 Mg Film Coated Tablets, Mebeverine+Simethicone, Mebeverine, Simethicone. These drug candidates are in various stages of clinical development as the company works toward FDA approval.